Carlyle amasses $20B for secondaries; pharma biotools VC picks up the pace; PE sponsor equity drops as lending picks up

Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: VC, PE and M&A September 5, 2025 The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data